Vestergaard P, Hansen H E
Acta Psychiatr Scand. 1980 Feb;61(2):152-6. doi: 10.1111/j.1600-0447.1980.tb00574.x.
In patients given long-term treatment with lithium maximum urine osmolality was measured after 26 h of dehydration and after intranasal administration of desamino-8-D-arginine vasopressin (DDAVP). A high correlation was found between the results of the two tests suggesting that the DDAVP test is a suitable method of assessing renal concentrating ability in lithium-treated patients.
对接受锂盐长期治疗的患者,在脱水26小时后以及经鼻给予去氨基-8-D-精氨酸加压素(DDAVP)后测量最大尿渗透压。发现两项测试结果之间存在高度相关性,这表明DDAVP测试是评估锂盐治疗患者肾脏浓缩能力的合适方法。